DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Weber JS, Gibney G, Sullivan RJ. et al.
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.

Lancet Oncol 2016;
17: 943-955

Download Bibliographical Data

Access:
Access: